Penumbra, Inc Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Penumbra, Inc stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $9.67M, a 9.11% increase year-over-year.
- Penumbra, Inc stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $8.87M, a 0.06% increase year-over-year.
- Penumbra, Inc stock issued during period, value, employee stock purchase plan for the quarter ending 2024-06-30 was $8.86M, a 5.68% increase year-over-year.
- Penumbra, Inc stock issued during period, value, employee stock purchase plan for the quarter ending 2023-06-30 was $8.38M, a 4.84% increase year-over-year.
- Penumbra, Inc stock issued during period, value, employee stock purchase plan for fiscal 2025 was $16.41M, a 7.23% increase from fiscal 2024.
- Penumbra, Inc stock issued during period, value, employee stock purchase plan for fiscal 2024 was $15.30M, a 2.72% increase from fiscal 2023.
- Penumbra, Inc stock issued during period, value, employee stock purchase plan for fiscal 2023 was $14.90M, a 8.21% increase from fiscal 2022.
- Penumbra, Inc stock issued during period, value, employee stock purchase plan for fiscal 2022 was $13.77M, a 0.45% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $9.67M 10-Q · filed 2026-07-30 | |
| 2025-12-31 | $16.41M 10-K · filed 2026-02-25 | |
| 2025-06-30 | $8.87M 10-Q · filed 2026-07-30 | |
| 2024-12-31 | $15.30M 10-K · filed 2026-02-25 | |
| 2024-06-30 | $8.86M 10-Q · filed 2025-11-05 | |
| 2023-12-31 | $14.90M 10-K · filed 2026-02-25 | |
| 2023-06-30 | $8.38M 10-Q · filed 2024-10-30 | |
| 2022-12-31 | $13.77M 10-K · filed 2025-02-18 | |
| 2022-06-30 | $8.00M 10-Q · filed 2023-11-02 | |
| 2021-12-31 | $13.71M 10-K · filed 2024-02-22 | |
| 2021-06-30 | $7.35M 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $11.30M 10-K · filed 2023-02-23 | |
| 2020-06-30 | $5.95M 10-Q · filed 2021-11-03 | |
| 2019-12-31 | $8.98M 10-K · filed 2022-02-22 | |
| 2019-06-30 | $4.78M 10-Q · filed 2020-11-02 | |
| 2018-12-31 | $7.23M 10-K · filed 2021-02-23 | |
| 2018-06-30 | $3.58M 10-Q · filed 2019-11-07 | |
| 2017-12-31 | $5.81M 10-K · filed 2020-02-26 | |
| 2016-12-31 | $2.78M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $6.58M 10-K · filed 2019-02-26 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | |
| 2016-06-30 | $3.80M 10-Q · filed 2016-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |